Cytostatic and Cytotoxic Effects of 5-Fluorouracil on Human Corneal Epithelial Cells and Keratocytes
- 1 March 2013
- journal article
- basic investigation
- Published by Wolters Kluwer Health in Cornea
- Vol. 32 (3) , 338-344
Abstract
Purpose: To investigate the effects of various 5-fluorouracil (5-FU) concentrations, exposure times, and application techniques on in vitro–cultured human corneal cells. Methods: Human corneal epithelial cell (HCEC) and human corneal keratocyte (HCK) cultures were exposed to different 5-FU concentrations (0.025%–1%) and incubation durations (5 minutes to 2 hours). The cytostatic effect was evaluated as the percentage of inhibition of migration relative to the control. The evaluation of cytotoxic effect included both phase contrast microscopic observations and viability measures performed using an MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)] colorimetric assay. The results are expressed as ratio of optical density (OD) reduction 24 hours after exposure. Results: The cytostatic effect was time and dose dependent. The 50% inhibiting dose was 0.55% after 1 hour of incubation for HCECs and was 0.5% after 2 hours of incubation for HCKs. A 100% inhibitory effect was never observed at any concentration or incubation duration. No cytotoxic changes were observed using an 5-FU concentration of <1%; 1% 5-FU showed time-dependent cytotoxic changes in HCEC cultures only. MTT analysis showed no OD reduction at 5-FU concentrations of <1%, whereas 1% 5-FU showed OD reduction <50% at any tested exposure time. HCECs showed higher reduction in OD than HCKs. Conclusions: 5-FU formulations topically used in clinical practice showed limited toxicity in normal cultured corneal epithelial cells and keratocytes.Keywords
This publication has 24 references indexed in Scilit:
- Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety studyBritish Journal of Ophthalmology, 2010
- Therapeutic Effect of Topical 5-Fluorouracil in Conjunctival Squamous Carcinoma Is Associated With Changes in Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases ExpressionCornea, 2009
- Modulation de la cicatrisation dans la chirurgie du glaucomeJournal Français d'Ophtalmologie, 2007
- The Clinical Applications of Fluorouracil in Ophthalmic PracticeDrugs, 2007
- Topical Medical Therapies for Ocular Surface TumorsSeminars in Ophthalmology, 2006
- 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and corneaOphthalmology, 2000
- Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracilBritish Journal of Ophthalmology, 2000
- Conjunctival Squamous Cell Carcinoma Treated With Topical 5-FluorouracilArchives of Ophthalmology (1950), 1997
- Topical 5-Fluorouracil in Treating Epithelial Neoplasia of the Conjunctiva and CorneaOphthalmology, 1995
- Serious Corneal Complications of Glaucoma Filtering Surgery With Postoperative 5-FluorouracilAmerican Journal of Ophthalmology, 1987